A Peek at Plus Therapeutics's Future Earnings

Plus Therapeutics PSTV is set to give its latest quarterly earnings report on Thursday, 2024-11-14. Here's what investors need to know before the announcement.

Analysts estimate that Plus Therapeutics will report an earnings per share (EPS) of $-0.56.

The announcement from Plus Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Earnings Track Record

The company's EPS missed by $0.18 in the last quarter, leading to a 1.41% drop in the share price on the following day.

Here's a look at Plus Therapeutics's past performance and the resulting price change:

Quarter Q2 2024 Q1 2024 Q4 2023 Q3 2023
EPS Estimate -0.53 -1.09 -1.07 -1.12
EPS Actual -0.71 -0.75 -0.70 -1
Price Change % -1.0% -3.0% -11.0% 6.0%

eps graph

Plus Therapeutics Share Price Analysis

Shares of Plus Therapeutics were trading at $1.29 as of November 12. Over the last 52-week period, shares are down 42.66%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Plus Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-EP
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!